Expand AQST Menu
AQST MENU

AQST Latest Press Releases

-- October 7, 2026 --

Aquestive Therapeutics, Inc. (Nasdaq: AQST) Investor Alert: Schubert Jonckheer Investigating Possible False Statements Following 37% Stock Drop PRNewswire 9:31 AM

-- September 29, 2026 --

Aquestive Therapeutics Strengthens Board of Directors with Appointment of Richard Daly Globe Newswire 7:00 AM

-- September 17, 2026 --

Aquestive Therapeutics Announces Resubmission of New Drug Application to FDA for Anaphylm (dibutepinephrine) Sublingual Film Globe Newswire 7:00 AM

-- September 1, 2026 --

Aquestive Therapeutics to Participate in Upcoming September Investor Conferences Globe Newswire 7:00 AM

-- August 11, 2026 --

Aquestive Therapeutics Reports Second Quarter 2026 Financial Results and Provides Business Update Globe Newswire 4:01 PM

-- August 10, 2026 --

Aquestive Therapeutics Announces Positive Topline Human Factors and Pharmacokinetic Study Results for Anaphylm (dibutepinephrine) Sublingual Film Globe Newswire 7:00 AM

-- July 29, 2026 --

Aquestive Therapeutics to Report Second Quarter 2026 Financial Results and Recent Business Highlights on August 11 and Host Conference Call on August 12 at 8:00 a.m. ET Globe Newswire 7:00 AM

-- July 7, 2026 --

Aquestive Therapeutics to Participate in Leerink Partners Therapeutics Forum: I&I and Metabolism Globe Newswire 7:00 AM

-- May 13, 2026 --

Aquestive Therapeutics Reports First Quarter 2026 Financial Results and Provides Business Update Globe Newswire 4:01 PM

-- May 12, 2026 --

Aquestive Therapeutics Completes $150 Million Debt Refinancing with Oaktree Globe Newswire 9:31 AM
Market Data Delayed 15 Minutes